US9553061055
© PR Newswire
12.12.2025
WST
LISTED
NYSE
West to Participate in Upcoming Investor Conference
News Preview
EXTON, Pa., Dec. 12, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 9:00 am PST in San Francisco, California....
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
WST
LISTED
NYSE
West Declares Quarterly Dividend
News Preview
EXTON, Pa., Dec. 10, 2025 /PRNewswire/ -- On December 9, 2025, the board of directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on February 4, 2026, t...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
WST
LISTED
NYSE
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
News Preview
EXTON, Pa., Oct. 27, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the launch of its West Synchrony™ Prefillable Syringe (PFS) System at CPHI Worldwide in Frankfurt, Germany. This innovative system m...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
24.10.2025
WST
LISTED
NYSE
West to Participate in Upcoming Investor Conferences
News Preview
EXTON, Pa., Oct. 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences: ...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
23.10.2025
WST
LISTED
NYSE
West Reports Third-Quarter 2025 Results
News Preview
- Delivered solid growth across Proprietary Products and Contract Manufacturing Segments - - Achieved double-digit growth in HVP Components -- Strengthened executive leadership team, including recently appointed CFO Robert McMahon -- Increases Full-Year 2025 Revenue and EPS Guidance -...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
WST
LISTED
NYSE
West to Host Third-Quarter 2025 Conference Call
News Preview
EXTON, Pa., Oct. 9, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 23, 2025, and will follow with a co...
Themefolio
Profiler
Peergroup
© PR Newswire
21.08.2025
WST
LISTED
NYSE
West to Participate in Upcoming Investor Conferences in September 2025
News Preview
EXTON, Pa., Aug. 21, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at multiple investor conferences in September. Here are the details of the presentations:...
Themefolio
Profiler
Peergroup
© PR Newswire
24.07.2025
WST
LISTED
NYSE
West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance
News Preview
- Conference Call Scheduled for 8 a.m. EDT Today -
EXTON, Pa., July 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2025 and a fourth-quarter 2025 dividend....
Themefolio
Profiler
Peergroup
© PR Newswire
21.07.2025
WST
LISTED
NYSE
West Welcomes Robert McMahon as Incoming Chief Financial Officer
News Preview
EXTON, Pa., July 21, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the appointment of Robert McMahon as the company's new Chief Financial Officer (CFO), effective August 4, 2025. Mr. McMahon will succeed Bernard Birkett, CFO, who ann...
Themefolio
Profiler
Peergroup
© PR Newswire
08.07.2025
WST
LISTED
NYSE
West to Host Second-Quarter 2025 Conference Call
News Preview
EXTON, Pa., July 8, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter financial results before the market opens on Thursday, July 24, 2025, and will follow with a conference call to discuss the results...
Themefolio
Profiler
Peergroup
© BusinessWire
07.07.2025
WST
LISTED
NYSE
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceuticals
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) and reminds investors of the July 7, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Fa...
Themefolio
Profiler
Peergroup
© BusinessWire
02.07.2025
WST
LISTED
NYSE
Deadline Soon: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming July 7, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inc...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
28.06.2025
WST
LISTED
NYSE
WST Deadline: Rosen Law Firm Urges West Pharmaceutical Services, Inc. (NYSE: WST) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025. West describes itself as a “medical supplies company specializing in packaging components, containmen...
Themefolio
Profiler
Peergroup
© BusinessWire
23.05.2025
WST
LISTED
NYSE
Kirby McInerney LLP Reminds West Pharmaceutical Services, Inc. (WST) Investors of Class Action Filing and Encourages Investors to Contact the Firm
News Preview
The law firm of Kirby McInerney LLP reminds investors who purchased West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE:WST) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud c...
Themefolio
Profiler
Peergroup
© BusinessWire
16.05.2025
WST
LISTED
NYSE
Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming July 7, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive...
Themefolio
Profiler
Peergroup
© BusinessWire
15.05.2025
WST
LISTED
NYSE
Deadline Approaching: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming July 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”).
IF YOU...
Themefolio
Profiler
Peergroup
© BusinessWire
14.05.2025
WST
LISTED
NYSE
Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”). West investors have until July 7, 2025 to file a lead plain...
Themefolio
Profiler
Peergroup
© BusinessWire
13.05.2025
WST
LISTED
NYSE
Rosen Law Firm Urges West Pharmaceutical Services, Inc. (NYSE: WST) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025. West describes itself as a “medical supplies company specializing in packaging components, containment soluti...
Themefolio
Profiler
Peergroup
© BusinessWire
13.05.2025
WST
LISTED
NYSE
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, incl...
Themefolio
Profiler
Peergroup
© BusinessWire
12.05.2025
WST
LISTED
NYSE
Law Offices of Howard G. Smith Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”). West investors have until July 7, 2025 to file a lead plainti...
Themefolio
Profiler
Peergroup
© BusinessWire
11.05.2025
WST
LISTED
NYSE
WST INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), have until July 7, 2025 to seek appointment as lead plaintiff of the West Pharmaceutical class action lawsuit. Caption...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
WST
LISTED
NYSE
Securities Fraud Investigation Into West Pharmaceutical Services, Inc. (WST) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY O...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
WST
LISTED
NYSE
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN WEST PHARMACEUTICAL SERVICES, INC. (WST), CONTACT THE LAW OFFICES OF HOWARD...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
WST
LISTED
NYSE
Securities Fraud Investigation Into West Pharmaceutical Services, Inc. (WST) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON WEST PHARMACEUTICAL SERVICES, INC. (WST), CLICK HERE TO INQUIRE ABOUT POTEN...
Themefolio
Profiler
Peergroup
© PR Newswire
07.05.2025
WST
LISTED
NYSE
West to Participate in Upcoming Investor Conferences
News Preview
EXTON, Pa., May 7, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the BofA Securities Annual Healthcare Conference on Wednesday, May 14, 2025 at 2:20 PM PT....
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
WST
LISTED
NYSE
WST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”), have until July 7, 2025 to seek appointment as lead plaintiff of the West Pharmaceutical class action lawsuit. Ca...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
WST
LISTED
NYSE
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against West Pharmaceutical Services, Inc. (“West” or “the Company”) (NYSE: WST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commiss...
Themefolio
Profiler
Peergroup
© BusinessWire
06.05.2025
WST
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) and reminds investors of the July 7, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Far...
Themefolio
Profiler
Peergroup
© BusinessWire
06.05.2025
WST
LISTED
NYSE
Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. and Certain of Its Executives
News Preview
Labaton Keller Sucharow LLP (“Labaton”) announces that, on May 5, 2025, it filed a securities class action lawsuit (the “Complaint”) on behalf of its client the New England Teamsters Pension Fund (“New England Teamsters”) against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) and certain West executives (collectively, “De...
Themefolio
Profiler
Peergroup
© PR Newswire
24.04.2025
WST
LISTED
NYSE
West Announces Leadership Changes
News Preview
Bernard J. Birkett Announces Intention to Retire from West, Company Initiates Search for a Successor
Shane Campbell Appointed Senior Vice President, Chief Proprietary Segment Officer
EXTON, Pa., April 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration...
Themefolio
Profiler
Peergroup
© PR Newswire
24.04.2025
WST
LISTED
NYSE
West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend
News Preview
- Conference Call Scheduled for 9 a.m. EDT Today -
EXTON, Pa., April 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2025 and declared a third-quarter 2025 dividend....
Themefolio
Profiler
Peergroup
© PR Newswire
10.04.2025
WST
LISTED
NYSE
West to Host First-Quarter 2025 Conference Call
News Preview
EXTON, Pa., April 10, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 24, 2025, and will follow with a conference call to discuss the resul...
Themefolio
Profiler
Peergroup
© PR Newswire
05.03.2025
WST
LISTED
NYSE
West to Participate in Upcoming Investor Conferences
News Preview
EXTON, Pa., March 5, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025 at 11:00 AM ET....
Themefolio
Profiler
Peergroup
© PR Newswire
20.02.2025
WST
LISTED
NYSE
West Announces Second-Quarter Dividend
News Preview
EXTON, Pa., Feb. 20, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2025 dividend of $0.21 per share. The dividend will be paid on May 7, 2025, to shareholders of re...
Themefolio
Profiler
Peergroup
© PR Newswire
13.02.2025
WST
LISTED
NYSE
West Announces Fourth-Quarter and Full-Year 2024 Results
News Preview
- Conference Call Scheduled for 9 a.m. EDT Today -
EXTON, Pa., Feb. 13, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024 and introduced 2025 financial guidance....
Themefolio
Profiler
Peergroup
© PR Newswire
30.01.2025
WST
LISTED
NYSE
West to Host Fourth-Quarter and Full-Year 2024 Conference Call
News Preview
EXTON, Pa., Jan. 30, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2024 financial results before the market opens on Thursday, February 13, 2025, and will follow with a conference cal...
Themefolio
Profiler
Peergroup
© PR Newswire
28.01.2025
WST
LISTED
NYSE
West Announces First-Quarter Dividend
News Preview
EXTON, Pa., Jan. 28, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2025 dividend of $0.21 per share. The dividend will be paid on February 11, 2025, to shareholders o...
Themefolio
Profiler
Peergroup
© PR Newswire
22.01.2025
WST
LISTED
NYSE
West Introduces Daikyo PLASCAP® RUV Closures in New Nested Format at Pharmapack
News Preview
EXTON, Pa., Jan. 22, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the introduction of Daikyo PLASCAP® Ready-to-Use Validated (RUV) closures in a new nested format available in multiple configurations at this year's Pharmapack event...
Themefolio
Profiler
Peergroup
© PR Newswire
06.01.2025
WST
LISTED
NYSE
West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor Conference
News Preview
EXTON, Pa., Jan. 6, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that Cindy Reiss-Clark, Sr. VP and Chief Commercial Officer; Chad Winters, VP of Finance and Chief Accounting Officer; and John Sweeney, VP of Investor Relations, will...
Themefolio
Profiler
Peergroup
© PR Newswire
11.12.2024
WST
LISTED
NYSE
West Elects New Director to the Board
News Preview
EXTON, Pa., Dec. 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Janet Haugen as its newest member. With the addition of Ms. Haugen, West's Board has 12 directors....
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2024
WST
LISTED
NYSE
West to Participate in Upcoming Investor Conferences
News Preview
EXTON, Pa., Oct. 29, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following conferences:...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2024
WST
LISTED
NYSE
West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend
News Preview
- Conference Call Scheduled for 9 a.m. EDT Today -
EXTON, Pa., Oct. 24, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2024 and declared a fourth-quarter 2024 dividend....
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2024
WST
LISTED
NYSE
West to Present on Large Volume Delivery Systems, Administration and Transfer Devices, and Prefillable Syringe Component Expertise at the PDA Conference
News Preview
EXTON, Pa., Oct. 22, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced participation in the 2024 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Phoenix, AZ to showcase its leadership and expertise on industry cha...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2024
WST
LISTED
NYSE
West to Host Third-Quarter 2024 Conference Call
News Preview
EXTON, Pa., Oct. 10, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 24, 2024, and will follow with a conference call to discuss the resu...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2024
WST
LISTED
NYSE
West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards
News Preview
EXTON, Pa., Oct. 9, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that it has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with Fox Chase Cancer Center, a part of the Temple University Hea...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2024
WST
LISTED
NYSE
West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference
News Preview
EXTON, Pa., Oct. 7, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Milan, Italy to showcase leadership and expertise on industry challenges and trends in packaging and containment....
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2024
WST
LISTED
NYSE
West to Participate in Upcoming Investor Conference
News Preview
EXTON, Pa., Sept. 5, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Global Healthcare Conference in London, UK on Wednesday, September 18, 2024, at 9:55 AM BST....
Themefolio
Profiler
Peergroup
© PR Newswire
25.07.2024
WST
LISTED
NYSE
West Announces Second-Quarter 2024 Results
News Preview
- Conference Call Scheduled for 9 a.m. EDT Today -
EXTON, Pa., July 25, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2024 and updated full-year 2024 financial guidance....
Themefolio
Profiler
Peergroup
© PR Newswire
11.07.2024
WST
LISTED
NYSE
West to Host Second-Quarter 2024 Conference Call
News Preview
EXTON, Pa., July 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter financial results before the market opens on Thursday, July 25, 2024, and will follow with a conference call to discuss the result...
Themefolio
Profiler
Peergroup
© PR Newswire
29.05.2024
WST
LISTED
NYSE
West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy
News Preview
CZ's Nested Vials are designed to meet the exterior dimensions of glass standard ISO 8362-1 and offer broad compatibility with various aseptic fill-finish equipment available in the market.
EXTON, Pa., May 29, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administr...
Themefolio
Profiler
Peergroup
© PR Newswire
28.05.2024
WST
LISTED
NYSE
West to Participate in Upcoming Investor Conference
News Preview
EXTON, Pa., May 28, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the William Blair 44th Annual Growth Stock Conference in Chicago, IL on Tuesday, June 4, 2024 at 8:00 AM CT....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
